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The Hyacinthaceae (sensu APGII), with approximately 900 species in about 70 genera, can be divided into
three main subfamilies, the Hyacinthoideae, the Urgineoideae and the Ornithogaloideae, with a small
fourth subfamily the Oziroe¨oideae, restricted to South America. The plants included in this family have
long been used in traditional medicine for a wide range of medicinal applications. This, together with
some signiﬁcant toxicity to livestock has led to the chemical composition of many of the species being
investigated. The compounds found are, for the most part, subfamily-restricted, with homoisoﬂavanones
and spirocyclic nortriterpenoids characterising the Hyacinthoideae, bufadienolides characterising the
Urgineoideae, and cardenolides and steroidal glycosides characterising the Ornithogaloideae. The
phytochemical proﬁles of 38 genera of the Hyacinthaceae will be discussed as well as any biological
activity associated with both crude extracts and compounds isolated. The Hyacinthaceae of southern
Africa were last reviewed in 2000 (T. S. Pohl, N. R. Crouch and D. A. Mulholland, Curr. Org. Chem., 2000, 4,
1287–1324; ref. 1); the current contribution considers the family at a global level.1 The Hyacinthoideae
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This review reects a (bracketed)† family and subfamily taxonomic
arrangement for the Hyacinthaceae sensu APGII.2 A subsequent
arrangement (APGIII)3 based on further molecular analyses is not
here adopted, where the Hyacinthaceae was hypothetically
included in an expanded circumscription of the Asparagaceae. In
that the group of plants here dealt with are monophyletic,4 the
systematic approach adopted for delimiting and naming family,
subfamily or tribal level classications ultimately has little bearing
in relation to this review. We have adopted largely the phylogenies
and generic concepts of Speta,5 Pfosser and Speta,4 andment of Chemistry, University of Surrey,
y of KwaZulu-Natal, 4041 Durban, South
iodiversity Institute, P.O. Box 52099, 4007
wn as ‘bracketed families’. These were
be circumscribed in a larger sense.
Chemistry 2013subsequent workers (Mart´ınez-Azor´ın et al.)6 who have considered
molecular, morphological and biogeographic characters in their
circumscriptions. Ali Syed et al.7 have provided an excellent over-
view of alternative and oen controversial systematic arrange-
ments, of primary and secondary centres of geographic diversity,
and the distribution of subfamilies and tribes at a global level. It
should be noted that such is the state of ux of generic circum-
scription in the Hyacinthaceae that when providing a subfamilial
classication for this unit (Asparagaceae subfamily Scilloideae
sensu APGIII) Chase et al.8 did not list genera names, which they
otherwise oﬀered withmost other expanded Asparagalean families
they treated. Given the past nomenclatural instability of the Hya-
cinthaceae, the names of plants under which the original phyto-
chemical and pharmacological work was conducted oen diﬀers
radically from the names accepted currently. For this reason we
here provide both current and reported names, with species
authors, to make clear this link. The literally reported (and
sometimes incorrectly spelt) taxon names and species authors (if
given) are provided in parentheses. The subfamilies are discussed
in turn, starting with the Hyacinthoideae as most work has been
conducted on this, the largest, subfamily. The Urgineoideae and
nally the Ornithogaloideae follow. No reported investigations into
the Oziroe¨oideae appear in the literature. Within each subfamily,
those species receiving a substantial amount of attention will be
discussed rst, followed by the genera grouped by region (Europe
and the Mediterranean, Middle and Far East and North Africa,
southern Africa and nally, in the case of the Urgineoideae, India).Nat. Prod. Rep., 2013, 30, 1165–1210 | 1165
NPR ReviewPlants have been considered on a regional basis as in many cases
the secondary metabolites found reect a strong geographic
pattern. Any early work on a genus is discussed before later work.1 The Hyacinthoideae
The subfamily Hyacinthoideae comprises more than 400
species in thirty-eight genera.5,7 The Hyacinthoideae are
distributed in sub-Saharan Africa, India, Madagascar, eastern
Asia, the Mediterranean region and Eurasia. Sub-Saharan Africa
appears to be the centre of origin for the subfamily, with a
secondary centre of diversication and radiation being the
Mediterranean region.7 Twenty genera of the Hyacinthoideae
have been investigated, with the bulbs receiving most attention.
The exception is Hyacinthus orientalis L., the owers of which
have been extensively examined. Homoisoavanones and spi-
rocyclic nortriterpenoids are widespread throughout the
subfamily with chalcones, xanthones, avonoids, alkaloids,
stilbenoids, chromones, norlignans and benzopyranones also
being reported.Sianne Schwikkard obtained her
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1166 | Nat. Prod. Rep., 2013, 30, 1165–1210Abegaz et al.9 and du Toit et al.10 have reviewed the phyto-
chemistry, biological activity, biosynthesis and synthesis of the
homoisoavanones. The homoisoavanones can be divided into
ve categories, the 3-benzyl-4-chromanones 1, the 3-hydroxy-3-
benzyl-4-chromanones 2, the 3-benzylidene-4-chromanones (E or
Z) 3, the 3-benzyl-chrom-2-en-4-ones 4 and the scillascillins 5.
The spirocyclic nortriterpenoids are generally of the lanosterol-
type, showing a wide range of substitution patterns. The genera
receiving the most attention, Eucomis L'He´r., Muscari Mill. and
Ledebouria Roth. will be discussed rst, followed by the lesser-
studied Eurasian and Mediterranean genera Leopoldia Parl.,
Scilla L., Barnardia Lindl., Othocallis Salisb., Oncostema Raf.,
Hyacinthus L., Bellevalia Lapeyr., Autonoe (Webb & Berthel.) Speta
and Hyacinthoides Medik. Lastly, the southern African genera
Drimiopsis Lindl. & Paxton, Resnova van der Merwe, Veltheimia
Gled., Merwilla Speta, Lachenalia J.Jacq. ex Murray,Neil Crouch PhD (Natal) has
worked as an ethnobotanist for
the South African National
Biodiversity Institute (SANBI)
for nearly 20 years, largely on
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Indigenous Knowledge Systems
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Honorary Professor in the School of Chemistry and Physics at the
University of KwaZulu-Natal, he explores his strong interest in the
chemistry, traditional use and biosystematics of the Hyacintha-
ceae, a plant family with a major centre of diversity in southern
Africa.
This journal is ª The Royal Society of Chemistry 2013
Review NPRPseudoprospero Speta, Schizocarphus van der Merwe and Spetaea
Wetchnig & Pfosser are dealt with.
The genus Eucomis is widespread throughout eastern and
southern Africa. It is used by traditional healers to treat a wide
range of complaints, including rheumatism, as an anti-inam-
matory and as a treatment for mental disease. Homoiso-
avanones and triterpenoid glycosides have been isolated from
the bulbs of many of the species investigated, with the homo-
isoavanones usually accumulating in the waxy layer between the
storage leaves of the bulb and the terpenoids in the bulb tissue.11
Early work on Eucomis bicolor Baker resulted in the isolation of
the yellow crystalline needles of eucomin 6 and the colourless
hexagonal plates of eucomol 7.12 The conguration at C-3 of
eucomol 7 was determined by CD experiments and conrmed by
X-ray analysis of the p-bromophenacyl derivative.13 Four addi-
tional homoisoavonoids have been isolated from the bulbs of E.
bicolor, (8–11)14,15 followed a number of years later by the iden-
tication of seven triterpenoid oligosaccharides (12–18).16,17 Scil-
lasaponin A 12 has a modied spirocyclic side chain at C-17 and
C-23 and has been found to inhibit cyclic AMP phosphodies-
terase (IC50 ¼ 11.5  105 M).16 Compounds 13, 14 and 16 were
found to be toxic to HeLa cells at concentrations of both 50 mg
ml1 and 5 mgml1.17 A later investigation of E. bicolor resulted in
the isolation of twelve compounds from the dichloromethane
extract and ten from the methanol extract. The dichloromethane
extract yielded the seven known compounds (7, 10, 19, 20, 21, 22
and 23) and ve novel triterpenoids (24 [the aglycone of 25], 26,
27, 28 and 29). The methanol extract was found to contain the
known homoisoavonoid 30 as well as nine novel lanosterol
glycosides (31–39).18This journal is ª The Royal Society of Chemistry 2013Eucomis autumnalis (Mill.) Chitt. (syn. Eucomis undulata
Aiton) bulbs are used in the Eastern Cape of South Africa to treat
cancer,19 and are used by Zulu traditional healers as an emetic
and enema to treat fevers, as well as for the treatment of skin
infections, biliousness, and urinary and respiratory infections.
It is also used as a charm against witchcra.20 Phytochemical
investigations of the bulbs of E. autumnalis have resulted in the
isolation of three homoisoavanones (40–42),14,21,22 two
dibenzo-a-pyrones (43–44),23 two spirocyclic nortriterpenoids
(20 and 45) and an acid, compound 46.24 The structures
assigned to compounds 43 and 44 were subsequently revised
and reported to be the corresponding xanthones.25 The
proposed structure for eucosterol 20 was conrmed by the X-ray
structure of the p-bromobenzenesulphonate derivative.26 The
extensive use of E. autumnalis by traditional healers for fever
and the treatment of skin conditions, in particular wounds,
boils and open sores, has led to extensive investigations into the
anti-inammatory and antibacterial eﬀects of extracts of the
leaves, bulbs and roots. The inhibition of prostaglandin
synthesis was assessed in terms of the inhibition of the cyclo-
oxygenase enzymes COX-1 and COX-2. COX-1 is found in
normal cells and serves to produce substances that protect the
stomach and kidneys (prostanoids). While both enzymes are
involved in the inammatory process, inhibition of COX-1 is
associated with gastro-intestinal and kidney related side eﬀects.
As such, a higher selectivity for COX-2 inhibition is preferred.27
Initial testing of the leaves, bulbs and roots of E. autumnalis
against COX-1 showed good activity from all extracts (leaf
extract IC50 ¼ 15 mg ml1, root extract 27 mg ml1 and bulb
extract 72 mg ml1).28,29 A comparison of the COX-1 and COX-2Nat. Prod. Rep., 2013, 30, 1165–1210 | 1167
NPR Reviewinhibitory activity of the leaf, root and bulb extracts, showed
that the leaf extract inhibited COX-1 to a greater extent while the
root and bulb extract showed greater inhibition of COX-2 (COX-
2/COX-1 of 0.7 and 0.8 respectively for the root and bulb
extracts).27,30 There has been some interest in the biological
eﬀects of plant lectins obtained from the bulbs of E. autumnalis.
These non-enzymatic proteins can bind, with high specicity
and reversibility, mono- and oligosaccharides. Cyclooxygenase
is a membrane-bound glycoprotein and as such could be
aﬀected by plant lectins. The partially puried lectin-like
protein extract of E. autumnalis was found to have very good
cyclooxygenase inhibitory activity (COX-1 inhibition of 88%)31 as
well as good activity against the Gram-positive bacterium
Bacillus subtilis (MIC of 0.2 mg ml1).32 Due to the widespread
use of the bulbs of E. autumnalis by South African traditional
healers, extensive work has been carried out on the factors1168 | Nat. Prod. Rep., 2013, 30, 1165–1210possibly aﬀecting the eﬀectiveness of the bulb extracts. Envi-
ronmental factors such as sunlight intensity, temperature and
watering as well as age of the bulbs and the eﬀect of cold storage
have all been examined.33 Bulbs lied and stored at a low
temperature (8–10 C) showed greater COX-1 inhibitory
activity.34 The leaves of young plants showed greater COX-1
inhibitory activity than those of older plants, where the greatest
activity was associated with bulbs and roots.35
Six homoisoavanones (19, 40, 47–50)14,36 and the optically
active 2-hydroxy-2-[(4-hydroxyphenyl)methyl]butanedioic acid
51 have been isolated from the bulbs of Eucomis comosa
(Houtt.) H. R. Wehrh. (as Eucomis punctata L'Herit).37 The
bulb wax of Eucomis comosa yielded the chroman-4-one 5238
while an examination of the methanol extract of the fresh,
air-dried bulbs gave ve homoisoavanones (47, 48, 50
and both the E and Z form of 6).39 The same study includedThis journal is ª The Royal Society of Chemistry 2013
Review NPREucomis pallidiora Baker subsp. pole-evansii (N.E.Br.) Reyneke
ex J.C.Manning and Eucomis schijﬃi Reyneke. The bulbs of
Eucomis pallidiora subsp. pole-evansii contained the homo-
isoavanone 53 and the spirocyclic nortriterpenoid 20 while
Eucomis schijﬃi yielded two compounds, the spirocyclic nor-
triterpenoid 54 and scillascillin 55.39 Eucomis montana Comp-
ton was investigated and the bulbs were found to contain
eleven homoisoavanones (6, 7, 9, 10, 30, 50, 56, 57, 58, 59 and
60).40 No inhibitory activity against cyclooxygenase enzymes
(COX-1 and COX-2) was found for compounds 48, 53 and 55
isolated from E. comosa, E. pallidiora and E. schijﬃi respec-
tively.39 Some antibacterial activity has been observed for
homoisoavanones isolated from E. comosa (MIC of 0.52 mM
for compound 6 (E isomer) and 0.24 mM for compound 47)
and E. schijﬃi (MIC of 0.50 mM for compound 55).41 The
dichloromethane and methanol extracts of the whole plant
of Eucomis vandermerwei I.Verd. yielded four known homoiso-
avanones (6, 7, 10 and 56).42 Similarly, the whole plant
of Eucomis zambesiaca Baker was investigated and this resultedThis journal is ª The Royal Society of Chemistry 2013in the isolation and identication of ve homoisoavanones
(6, 19, 40, 61 and 62) and three nortriterpenoids (20, 21
and 63).42
The bulbs of Muscari racemosum Mill. were found to contain
homoisoavanones of the 3-benzylidene-4-chromanone-type
(64–66).43 Long-range coupling between C-2 and C-9, was
indicative of Z geometry. These homoisoavanones have been
investigated with respect to their eﬀect on lipid peroxidation in
vitro.44,45 Strong anti-oxidant activity was noted (IC50¼ 0.94–7.98
mM) and this led to an investigation into their antimutagenic/
anticarcinogenic activity. It has been suggested that poly-
phenolics may be cancer preventative due to their antioxidant
properties44 and a mixture of these three homoisoavanones
was found to contain signicant antimutagenic activity.44
Estrogenic activity was found in an ether extract of the bulbs.
The extract induced proliferation of MCF7 cells in a dose
dependent manner at concentrations up to 5 mg ml1. This
concentration produced the greatest eﬀect of 181% of the
control.46Nat. Prod. Rep., 2013, 30, 1165–1210 | 1169
NPR ReviewA wide range of compounds has been isolated from the
bulbs of Muscari armeniacum Leichtlin ex Baker. These include
avonoids (67–69),47 homoisoavanones, with an unusual 30,40
substitution pattern in the B ring (30, 62, 70–80),48,49 spirocyclic
nortriterpenoid glycosides (81–87)50 and polyhydroxylated pyr-
rolizidine alkaloids (88–92).51 The alkaloids were assessed for
their action against glycosidases. Compound 88 was found to
be a potent inhibitor of rat intestine lactase (IC50 ¼ 4.4 mM) as
well as a moderate inhibitor of a-L-fucosidase (IC50 ¼ 46 mM)
and amyloglucosidase (IC50 ¼ 25 mM). Inverting the hydroxyl
group at C-1 to give compound 89, enhanced the1170 | Nat. Prod. Rep., 2013, 30, 1165–1210amyloglucosidase inhibition (IC50 ¼ 8.6 mM) but resulted in
the loss of the a-L-fucosidase inhibition. Compounds 90 and 91
were less active.51 Three ribosome-inactivating proteins have
been isolated from the bulbs of M. armeniacum. It has been
proposed that this type of activity is linked to an anti-viral
response.52 The petals of M. armeniacum have yielded four
anthocyanins, the new muscarinin A 93 and the known 3-O-b-
D-glucopyranoside of delphinidin, petunidin and malvidin (94–
96).53–55 The principle water soluble polysaccharide in the bulbs
of M. armeniacum (as Muscari szovitsianum Baker) was found to
be a neutral glucofructan, with glucose and fructose residues
in the ratio 26 : 1.56,57
Phytochemical investigations into the bulbs of Muscari
botryoides (L.) Mill. conrmed a close taxonomic relationship
with Muscari armeniacum. Similar homoisoavanones (19, 30,
58, 60, 77, 79, 97, 98)48 were isolated as well as similar spi-
rocyclic nortripertenoid glycosides (86, 87, 99, 100, 101, 102,
103).50 Muscari neglectum Guss. ex Ten. was found to contain a
similar spread of homoisoavanones in the bulbs (30, 62, 80,
104–107) as well as an interesting scillascillin-type homoiso-
avanone with an unusual oxygenation pattern in the B ring
(55).58 Ethanol extracts of the bulbs and leaves of Muscari
neglectum have been tested for antifungal activity against the
wood rots Postia placenta and Trametes versicolor. Signicant
reduction in wood weight loss was observed for Turkish oriental
beech and Scots pine (weight loss dropped from 35–42% in the
untreated wood to 5.4–18.3% in the treated wood).59This journal is ª The Royal Society of Chemistry 2013
Review NPRAn aqueous ethanol extract of the bulbs of Ledebouria socialis
(Baker) Jessop (as Scilla socialis Baker) was found to contain
eleven hyacinthacines (108–118) as well as two pyrrolidines
(119–120) and three piperidines (121–123).60 Hyacinthacines
appear to be restricted to the Hyacinthoideae. These
compounds have been found in Othocallis siberica (Haw.) Speta
(as Scilla sibirica), Oncostema peruviana (L.) Speta (as Scilla
peruviana), Hyacinthoides non-scripta (L.) Chouard ex Rothm.,
Hyacinthoides hispanica (Mill.) Rothm. (as Scilla campanulata),
and Muscari armeniacum. The hyacinthacines are characterised
as 7a-R-hydro-1,2-dihydroxy-3-hydroxymethylpyrrolizidines and
in general appear to be weak to moderate inhibitors of glyco-
sidases.60 The dichloromethane and methanol extracts of the
bulbs of Ledebouria socialis have yielded ve compounds, the
scillascillin-type homoisoavanones 124 and 125, phytol, stig-
masterol and the polyhydroxylated difuran derivative, poly-
botrin 126.61 The diﬀerent types of compounds isolated reect
the diﬀerent solvents used for extraction, with the more polar
extracts yielding the more polar polyhydroxy alkaloids and the
less polar extracts the homoisoavanones and sterols.This journal is ª The Royal Society of Chemistry 2013Early work by Gunn et al.62 on some southern African Lede-
bouria species, examined the cardiac eﬀect of Ledebouria cooperi
(Hook.f.) Jessop (as Scilla cooperi Hook and as Scilla rogersii
Baker) and Ledebouria ovatifolia (Baker) Jessop (as Scilla lan-
ceaefolia Baker). Both species produced a similar action to
digitalis when applied to isolated frog and cat hearts as well as
in situ frog, cat and dog hearts. The extracts obtained were,
however, insuﬃcient in quantity to determine minimum lethal
doses and the active components were not identied.
The chemical constituents of a further six southern African
Ledebouria species have been investigated. Two samples of the
bulbs of Ledebouria zebrina (Baker) S.Venter (as Scilla zebrina
Baker), collected from two diﬀerent regions in South Africa
(Durban and Blyde River, Mpumalanga) have been investigated
and the chemical diﬀerences noted. Both contained homo-
isoavanones (Durban bulbs compounds 127 and 128 and the
Blyde River bulbs compounds 127, 129, 130). In addition to the
homisoavanones, the Blyde River bulbs also contained spi-
rocyclic nortriterpenoids (131, 21), while the Durban bulbs
produced a chalcone 132.63 The bulbs of Ledebouria cooperiNat. Prod. Rep., 2013, 30, 1165–1210 | 1171
NPR Reviewyielded the homoisoavanones 59 and 62 as well as the
eucosterol-type spirocyclic nortriterpenoid 133 and malic acid.
Ledebouria ovatifolia bulbs were found to contain the chalcones
132 and 134 as well as the homoisoavanone 30.64,65 L. ovati-
folia is used by the Zulu to treat gastro-enteritis, inuenza and
backache. In addition, it has been found to be toxic to sheep.66
Extracts of the bulbs were found to have good antibacterial
activity against Gram-positive bacteria (MIC of 0.8–12.5 mg
ml1), but poor anti-inammatory and poor antihelmintic
activity.66,67 A later investigation of the dichloromethane, ethyl
acetate and methanol extracts of the bulbs led to the isolation
of twenty-nine compounds, including xanthones (135–138),
homoisoavanones (7, 10, 30, 50, 74, 75, 139–148), triterpe-
noids (133, 149–150), chalcones (132, 151) and simple aromatic
compounds (152–154), including polybotrin 126.61,68 Sixteen of
the above compounds isolated from L. ovatifolia were assessed
for anti-inammatory activity, in particular the selective inhi-
bition of the COX-2 enzyme. Compounds 75, 137 and 146 were
found to signicantly inhibit COX-1 and COX-2 (percentage
activity relative to the non-inhibitor control of 54–56% for
COX-1 and 0% for COX-2), while compound 145 showed good
selectivity for the inhibition of COX-2 over COX-1 (IC50 for
COX-2 of 2.87 mM, with no statistically signicant inhibition
for COX-1 up to a concentration of 20 mM).61,68 During the same
study, the norlignan hinokiresinol 155, previously isolated
from Drimiopsis burkei Baker,69 was synthesised and tested for
selective COX-2 inhibitory activity. Signicant selective inhibi-
tion against COX-2 was observed (percentage activity relative to
the non-inhibitor control of 93.8% for COX-1 and 0% for1172 | Nat. Prod. Rep., 2013, 30, 1165–1210COX-2).61,68 Ledebouria leptophylla (Baker) S.Venter (as Lede-
bouria graminifolia (Baker) Jessop), sourced in Botswana, is
used traditionally to treat gastro-enteritis, backache and
coughs as well as a treatment for skin irritations and for
dressing wounds. A phytochemical investigation of the bulbs
found seven 3-benzyl-4-chromanones (30, 62, 128, 156–159),
two 3-benzyl-3-hydroxy-4-chromanones (7, 57), two scillascillin-
type homisoavanones (160–161) and two xanthones (136 and
162). Cultivated and wild-sourced bulbs contained the same
compounds.70,71 There was initial concern about the presence
of the xanthones and speculation as to whether they may have
come from a fungal or lichen contamination of the wild bulbs.
The fact that the cultured bulbs contained the same
xanthones conrmed that they were secondary metabolites of
L. leptophylla.72
Within South Africa Ledebouria revoluta (L.f.) Jessop is
extremely widespread. It is used by the Sotho to drive away
lightening and with the exception of pregnant women, to treat
lumbago. The Kwena and Tswana use it to treat wounds and skin
conditions. The bulbs were found to contain homoisoavanones
(30, 59, 61 and 157).73 Ledebouria oribunda (Baker) Jessop is used
by traditional healers in the Eastern Cape of South Africa to treat
skin disorders, tuberculosis, urinary tract infections and gastro-
enteritis. Three homoisoavanones, with unusual substituents at
C-6, -7 and -8 (163–165) have been isolated from the bulbs as well
as two 7-O-diglycosides (166–167) and ve additional homoiso-
avanones (10, 30, 50, 62, 168). These latter seven homoiso-
avanones have shown good antioxidant activity against the
DPPH radical (IC50 of 31–273 mg ml
1) and in the b-carotene/This journal is ª The Royal Society of Chemistry 2013
This journal is ª The Royal Society of Chemistry 2013 Nat. Prod. Rep., 2013, 30, 1165–1210 | 1173
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NPR Reviewlinoleic acid system (antioxidant activity of up to 79% aer 120
min) as did 164 and 165 against the DPPH radical (IC50 of 23.2
and 28.7 mg ml1 respectively).74,75
Leopoldia comosa (L.) Parl. is found largely in the Mediter-
ranean region and the bulbs have been used as a food source for
generations.76 Evidence for the ancient use of this plant
includes the discovery of traces of this species in a Neanderthal
grave in Iraq.77 The bulbs (as Muscari comosum Mill.) were
examined for antioxidant activity as part of a study on non-
cultivated vegetables commonly consumed by Albanians living
in southern Italy. Twenty-seven plant species were investigated,
with two showing high activity, one of which was L. comosa
(inhibitory activity on a DPPH assay of 85%).78 A further study
also found good antioxidant activity as well as hypoglycemic
activity via the inhibition of carbohydrate digestive enzymes.79
Extracts of L. comosa (as Muscari comosum Mill.) have been
found to be eﬀective in combatting the wood rot fungus Postia
placenta in samples of Pinus sylvestris L. and Fagus orientalis.80
Phytochemical studies on L. comosa (as Muscari comosum Mill.)1174 | Nat. Prod. Rep., 2013, 30, 1165–1210have resulted in the isolation of nineteen nortriterpenoids of
the lanosterol-type as well as homoisoavanones.
Initial work on the bulbs was complicated by the presence of
complex glycosides. Acid catalysed methanolysis of the glyco-
side mixture resulted in the identication of the aglycones.
Eucosterol 20 was found to be the major component, with
compounds 21, 54, 169, 170 and 171 present in smaller
amounts.76,81–84 Extensive work on the bulbs by Adinol et al.
resulted in the isolation of the free aglycones present in the
bulbs (20, 21, 22, 54, 169–175)85–89 as well as the full structural
elucidation of the glycosides (86, 87, 102, 103 and 176).90–94 All
the nortriterpenes isolated from Leopoldia comosamentioned so
far have S conguration at C-23, three compounds with R
conguration have also been identied, 177,91 178 (23R 20) and
179 (23R 170).89
Two classes of homoisoavanones have been isolated from
the bulbs of L. comosa, the 3-benzyl-4-chromones (30, 58, 59, 61,
62, 80, 97, 180–181)95,96 and the scillascillin type (55, 104–107
and 182).97,98 The absolute conguration at C-3 of theseThis journal is ª The Royal Society of Chemistry 2013
Review NPRhomoisoavanones was determined using circular dichroism
and found to be R in all cases.99 For the scillascillin type, this
was further conrmed by X-ray analysis.98 The crude extract of
the bulbs has been subjected to anti-inammatory bioassay-
directed fractionation using a croton oil-induced mouse ear
dermatitis test. The homoisoavanone rich fraction was found
to have high activity and further fractionation resulted in the
isolation of 30, 59, 61, 80 and 97, all of which showed activity,
with compound 30 being the most active at 41% inhibition (100
mg ear1).100 Two avonoids have been isolated from the owers
of L. comosa, 3-glucoarabinosyl- and 3-rhamnoarabinosyl-3,4,5-
trihydroxy-7-alkoxyl avone.101
Leopoldia comosa is used in the Basilicata region of southern
Italy to treat toothache and headache.102 One third of the plants
used for medicinal purposes in southern Italy are used to treat
skin and so tissue infections. As Staphylococcus aureus is a
common cause of such infections, the eﬀect of a number of
Italian plants, including the bulbs of Leopoldia comosa, on the
inhibition of the S. aureus biolms has been studied. Signicant
dose-dependent biolm inhibition (IC50 ¼ 16 mg ml1) was
noted for L. comosa.103
Investigations into the chemistry of the bulbs of Scilla
luciliae (Boiss.) Speta (as Chionodoxa gigantea Whittall and as
Choinodoxa luciliae Boiss.) has yielded a large number of lan-
osterol-type spirocyclic nortriterpenoids, many of which have
been tested for biological activity. Compounds 183–18616,104
and compounds 13 and 187–18817 have been isolated from the
bulbs of Scilla luciliae (as Chionodoxa gigantea). In separate
investigations, compounds 13, 184 and 187–19017 as well as
compounds 189 and 190–197 and eucosterol 20,105 compounds
198–204,106 205–207107 and 208–209108 have been found in the
bulbs of this species (as C. luciliae). Compounds 183–186 allThis journal is ª The Royal Society of Chemistry 2013showed some inhibitory activity on cyclic AMP phosphodies-
terase, with compound 183 giving the best results (IC50 ¼ 11.2
 105 M).104 Cytotoxicity against HeLa cells was assessed for
13, 184, 187, 188, 189, and 190 with the 15-deoxoeucosterol
oligosaccharides (13, 187 and 190) showing good activity down
to 5 mg ml1.17 Compounds 198–204 as well as 183 and 185
were tested for activity against HSC-2 human oral squamous
carcinoma cells. Compounds 183, 185, 200, 201 and 204 all
gave good results with LD50 values in the range 10–23 mg ml
1
(etoposide LD50 ¼ 24 mg ml1, for etoposide resistant HSC
cells). It was noted that the 23R isomer of 185, compound 186
did not show any activity.106 Compounds 208 and 209 showed
only weak activity in the same assay (LD50 of 254 and 238 mg
ml1 respectively).108 In addition to the spirocyclic nor-
triterpenoids, the bulbs of Scilla luciliae (as Chionodoxa luci-
liae) have been found to contain the homoisoavanones 210–
222.109
The bulbs and aerial parts of Scilla bifolia L. have been
studied using HPLC and mass spectrometry. Eighteen poly-
phenols were identied from extracts of the bulbs and aerial
parts (caaric acid, isoquercitin, routine, myricetol, stein,
quercetol, patuletin, gentisic acid, caﬀeic acid, chlorogenic
acid, p-coumaric acid, ferulic acid, hyperoside, quercitrin,
luteolin, kaempferol, apigenin and sinapic acid).110
The methanol and aqueous ethanol extracts of the bulbs of
Autonoe madeirensis (Menezes) Speta (as Scilla maderensis
Menezes), a species endemic to the Portuguese archipelago of
Madeira, was found to produce cardiac action on a frog heart
and although TLC showed compounds with Rf values and
colours very similar to the bufadienolides proscillaridin A 223
and scillaren A 224, typical of the Urgineoideae, the presence of
these compounds was not conclusively established.111Nat. Prod. Rep., 2013, 30, 1165–1210 | 1175
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loides (Lind.) Druce) has been used for a long time by traditional
Chinese healers to treat abscesses and to promote circulation.112
This plant also grows extensively in the wild in Japan and Korea
and has been used by traditional healers of the latter country.113
The root extract has been evaluated for its potential as an anti-
microbial agent, as an anti-inammatory and as an antioxi-
dant.113 The root extract of B. japonica (as Scilla scilloides) was
found to inhibit the growth of Staphylococcus aureus, Salmonella
enteritidis, Escherichia coli and Candida parapsilosis down to a
concentration of 0.1% of the extract. Antioxidant activity was
evaluated by looking at the inhibition of hyaluronidase, an
enzyme that initiates the degradation of hyaluronic acid, asso-
ciated with inammation. Inhibition was noted at concentra-
tions of root extract of 0.1 (14.8% inhibition) and 1% (48.2%
inhibition), but not below. Anti-oxidant activity was assessed by
monitoring the oxidation of linoleic acid and good activity was
found (anti-oxidative index of 33.2 at a concentration of 1%).113
Extensive phytochemical investigations of the bulbs of B. japonica
(as Scilla scilloides) resulted in the isolation of spirocyclic nor-
triterpenes (21, 22, 131, 225, 226 and 227),114,115 the relatedThis journal is ª The Royal Society of Chemistry 2013oligoglycosides (187, 228–239 and 241–247)112,116–118 and homo-
isoavanones (42, 55 and 248).119 Nishida et al.120 reported the
isolation of sixteen compounds from the methanol extract of the
bulbs, including three nortriterpenes (21, 22, and 225), a lignan
249, a xanthone 137, two homostilbenes (250 and 251) and nine
homoisoavanones (49, 55, C-3 epimer compound of 62, 182,
252, 253,and 254–156). The conguration at C-3 for 253, 254 and
the epimer of compound 62 was unusually found to be S by
circular dichroism.120 Scillascilloside E-3 239 and scillascilloside
E-1 237 have shown potent cytotoxicity against a range of human
cancer cells (ED50 1.5–3.0 nM and 1.6–5.9 nM respectively).112,117
Patents have been led covering the use of B. japonica (as Scilla
scilloides) bulb extracts for the treatment of fungal infections121
and as a treatment for cancer.122 A later investigation into the
methanol extract of the bulbs resulted in the isolation of two
norlanostane-type triterpenoid glycosides (257 and 258), a phe-
nylpropanoid glycoside 259 and two alkaloids (260 and 261).123
The aqueousmethanol extract of the bulbs of B. japonica (as Scilla
japonica) produced some cardiac action on an isolated toad heart
muscle, although the active components responsible were not
identied.124
Othocallis siberica (as Scilla sibirica Haw.) is native to south-
western Russia, the Caucasus and Turkey. The bulbs were found
to contain 0.04% glycosides and 0.15% alkaloids, with the
alkaloid fraction being able to stop the function of an isolated
frog heart. The glycoside fraction showed a strong hypertensive
action and was a stimulant to respiration.125 The hot water
extract of the bulbs produced an acylated glucomannan with D-
mannose, D-glucose and an acyl group in a ratio of
7.7 : 1 : 2.4.126 As part of their investigations into potential
glycosidase inhibitors, Yamashita et al. examined the ethanol
extract of the bulbs ofO. siberica (as Scilla sibirica). They isolatedNat. Prod. Rep., 2013, 30, 1165–1210 | 1177
1178 | Nat. Prod. Rep., 2013, 30, 1165–1210 This journal is ª The Royal Society of Chemistry 2013
NPR Review
Review NPRand identied ve pyrrolidines (262–266), two pyrrolidine
glycosides (267–268), six piperidines (269–274), one piperidine
glycoside (275) and eight pyrrolizidines (276–283).127 These
alkaloids were tested for their inhibitory activity against various
glycosidases. Compound 262 was found to be a potent inhibitor
of bacterial (Caldocellum sacchrolyticum) b-glucosidase and
mammalian b-galactosidase (IC50¼ 3.2 mg ml1 and 4.4 mg ml1
respectively). The loss of the hydroxy group at C-6, to giveThis journal is ª The Royal Society of Chemistry 2013compound 263, signicantly lowered the activity. Moderate or
no activity was found for all other compounds isolated.127
The bulbs of Oncostema peruviana (as Scilla peruviana) were
found to contain rearranged lanosterol glycosides (scillasapo-
nin B 284, peruvianoside A 285, peruvianoside B 286, and
compounds 187–188 and 287–288)16,17,128,129 as well as a range of
polyhydroxylated pyrrolidines (289–291) and pyrrolizidines
(292–295).130 Moderate inhibitory activity against cyclic AMPNat. Prod. Rep., 2013, 30, 1165–1210 | 1179
NPR Reviewphosphodiesterase was noted for peruvianoside A 285 (IC50 ¼
23.5  105 M) and scillasaponin B 286 (IC50 ¼ 14.0  105
M),16,128 while compound 187, a 15-deoxoeucosterol oligosac-
charide, was found to be toxic to HeLa cells at a concentration of
5 mg ml1.17 The pyrrolidine 291 was found to be a potent1180 | Nat. Prod. Rep., 2013, 30, 1165–1210inhibitor of bacterial b-glucosidase (IC50 ¼ 80 nM), compounds
292 and 293 showed signicant inhibition of yeast a-glucosi-
dase (IC50 ¼ 6.6 and 6.3 mM respectively) with compound 293
also showing good inhibition of bacterial b-glucosidase (IC50 ¼
5.1 mM).130This journal is ª The Royal Society of Chemistry 2013
Review NPRPhytochemical work on the Hyacinthaceae has primarily
focused on the bulbs. The exception to this has been the genus
Hyacinthus, where most of the work has been done on the owers.
Hyacinthus orientalis is used as an ornamental plant and can have
blue, pink, yellow or white owers. The blue owers ofH. orientalis
have been found to contain a range of acylated anthocyanins
(296–302).131 The anthocyanin content was also studied in the blue
owers produced in vitro. The same anthocyanins were produced
with some small changes in the percentage composition of the
diﬀerent compounds.132 The red owers of H. orientalis likewise
produced a range of acylated anthocyanins (303–316) and, as with
the blue owers, the red owers produced in vitro produced the
same anthocyanins with some diﬀerences in composition.133–135 A
later investigation of the blue owers of H. orientalis revealed a
further seven anthocyanins (317–323) in addition to those isolated
previously.136 Diﬀerences in essential oil content between wild H.
orientalis owers and those generated in vitro have been studied.
Four common components were found, 1-hepten-3-ol, benzylThis journal is ª The Royal Society of Chemistry 2013alcohol, phenethyl alcohol and cinnamyl alcohol. The main
components in the wild owers were phenethyl alcohol (55% at
stage 3 and 48% at stage 4) and cinnamyl alcohol (23% at stage 3
and 29% at stage 4) while the in vitro generated owers produced
75% phenethyl alcohol as the major component.137 The bulbs of
H. orientalis were found to be rich in polyhydroxy alkaloids.
a-Homonojirimycin 324 was the major component138 with the
compounds 325–334 being found in smaller amounts.138,139
Compound 332 was found to be a good inhibitor of bacterial
b-glucosidase (IC50 ¼ 3.8 mM), mammalian b-galactosidases
(IC50 ¼ 4.0 mM and 4.4 mM) and mammalian trehalases (5.0 mM
and 2.0 mM), while compound 333 inhibited rice a-glucosidase
(IC50 ¼ 2.2 mM) and rat intestinal maltase (IC50 ¼ 2.5 mM) and
compound 334 inhibited a-L-fucosidase (IC50 ¼ 50 mM).139
Themethanol extract of the bulbs of Bellevalia paradoxa (Fisch.
& C.A.Mey.) Boiss. (as Muscari paradoxum (Fisch. et C.A. Mey.)
K.Koch) yielded eight 27-norlanostane glycosides (335–342)55 and
seven tetranorlanosterol glycosides (25, 343–348).54 All were testedNat. Prod. Rep., 2013, 30, 1165–1210 | 1181
NPR Reviewfor cytotoxicity against HSC-2 human oral squamous cell carci-
noma. Compounds 25 and 343–344 showed no activity while
compounds 345–348 gave IC50 values of 6.3–59 mg ml
1, with the
standard etoposide giving an IC50 of 24 mg ml
1. Compounds 335,
336, 338, 340 and 341, all 23S isomers, showed good activity
relative to etoposide, but the corresponding 23R isomers showed
no activity up to a dose of 100 mgml1. Themethanol extract of the
bulbs of Bellevalia romana (L.) Sweet produced oligoglycosides of
the eucosterol-type, four new compounds bellevaliosides A 349, B
350, C 351 and D 352 as well as compounds 86, 87 and 353,
previously isolated from Muscari species.140 In addition to the
spirocyclic nortriterpenoids, ve homoisoavanones (354–358)
were isolated.141 The bulbs of Autonoe madeirensis (as Scilla
maderensis Menezes), have produced a slightly unusual phyto-
chemical prole. An investigation of the ethanol extract of the
bulbs resulted in the isolation of a range of 2-hydroxy di- and
tricarboxylic acids and esters, cis- and trans-hydroxycinnamate
esters and a avone diglucoside 359.142 A later study of the bulbs
found 24S-ethyl-5a-cholesta-7,22E-dien-3-ol-b-galactopyranoside
360 to be present.143 Dias et al. isolated the pyrimidine derivative
2-(40-aminobenzenamine)-pyrimidine and found it to be an
a-adrenoreceptor antagonist.144
Work on the bulbs of Hyacinthoides hispanica (as Scilla
campanulata) has focused on the isolation and structure deter-
mination of a mannose-specic lectin. Crystals have been
grown and the structure determined by X-ray diﬀraction1182 | Nat. Prod. Rep., 2013, 30, 1165–1210studies.145–149 In addition to the mannose-binding lectin, a
fetuin-binding lectin has been isolated and identied.150 Poly-
hydroxylated alkaloids have been isolated from the ethanol
extract of the bulbs of H. hispanica (as Scilla campanulata) and
tested for glycosidase inhibitory activity. Compounds 361–368
were identied with compound 364 showing good inhibition of
Caldocellum saccharolyticum b-glucosidase (IC50 ¼ 3.8 mM) and
bovine liver b-galactosidase (IC50¼ 4.4 mM). Compound 366was
more active than compound 364 against Caldocellum saccha-
rolyticum b-glucosidase (IC50 ¼ 0.34 mM), but less so of bovine
liver b-galactosidase (IC50 ¼ 24 mM).151
Hyacinthoides non-scripta (bluebells) has long been known to
be toxic to livestock. Horses suﬀer from abdominal pain and
dysentery while cattle suﬀer from lethargy and dullness aer
consuming the plants. The toxic principles are the polyhydroxy
pyrrolidine and pyrrolizidine alkaloids, common to many Hya-
cinthoideae.151,152 Alkaloids 361–367, also found in Hyacin-
thoides hispanica (as Scilla campanulata), have been isolated
from the leaves, stalks and immature fruits of the blue-
bells.151,152 A glucomannan has been isolated from the seeds of
H. non-scripta. It is a linear polymer with D-glucopyranose and D-
mannopyranose residues occurring in the ratio of 1 : 1.3.153
Southern African genera that have received the attention of
phytochemists are Drimiopsis, Resnova, Veltheimia, Merwilla,
Lachenalia, Pseudoprospero, Schizocarphus and Spetaea. The range
of compounds isolated is typical of the subfamily Hyacinthoideae,This journal is ª The Royal Society of Chemistry 2013
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xanthones, as well as some more unusual alkaloids. Three species
of Drimiopsis have been studied, Drimiopsis maculata Lindl. &
Paxton, Drimiopsis burkei and Drimiopsis barteri Baker. Drimiopsis
maculata is a southern African species used by traditional healers
for treating a variety of complaints, including stomach complaints
in children and the relief of constipation. It has not been found to
be toxic to livestock.25 The bulbs of this plant have yielded scil-
lascillin-type homoisoavanones (compound 106, previously iso-
lated from Muscari botryoides and compound 182, previously
isolated from M. botryoides and M. armeniacum),154 xanthones
(drimiopsins A–E, 163, 369, 138 and 370–372),25 three homoiso-
avanones (30, 59, 373) and a norlignan 374.69 Drimiopsis burkei is
widespread throughout Botswana and Zimbabwe, occurring
southward towards the Eastern Cape Province of South Africa.69 In
Botswana it is known as thejane and is used to treat stomach
complaints.155 A sample of this plant collected in KwaZulu-Natal,
South Africa was found to contain the norlignan hinokiresinol 155
and a homoisoavanone 375,69 while a sample collected in
Mochudi, Botswana was found to contain the scillascillin-type
homoisoavanones (248 and 376), xanthones (137, 138, 369,
377–378), the norlignan hinokiresinol 155 and the1184 | Nat. Prod. Rep., 2013, 30, 1165–1210homoisoavanones (E- eucomin 6, 104, 128 and 379–382).155 Dri-
miopsis barteri is the only genus member to occur in Cameroon,
where it is used to treat fever.156 The bulbs have been found to
contain the unusual isoquinoline alkaloids (383 and 384) as well as
the more expected scillascillin-type homoisoavanones (161, 376,
385–387), 3-benzyl-4-chromanones (61, 214 and 388) and Z-euco-
min 6. While the conguration at C-3 was not specied, the data
compared favourably to known compounds of this type and would
appear to be R.155,156 The homoisoavanones 144, 373, 375, 387 and
389–391, were tested against the Gram-positive, methicillin-resis-
tant Staphylococcus aureus. Compound 391 was found to have
signicant inhibitory activity with an MIC value of 0.47 mM.
Compounds 389 and 375 showed some activity, but the quantities
available were insuﬃcient for conclusive testing.41 The homoiso-
avanone 389, showed signicant vasodilating eﬀects when tested
on rat aortic rings (inhibition of the contraction elicited in aorta
rings by high K+ gave pIC50 of 5.31 M). This result would serve to
validate the use of these bulbs for the treatment of conditions
involving vasoconstriction.157 Resnova humifusa (Baker) U.Mu¨ll.-
Doblies & D.Mu¨ll.-Doblies, a South African species, earlier placed
in Drimiopsis by Jessop40 was found to contain nine homoiso-
avanones (7, 10, 30, 56–60, 392). The same study reported sevenThis journal is ª The Royal Society of Chemistry 2013
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Eucomis montana (7, 10, 30, 56, 58, 59, 60), which in addition
contained compound 8.40 A later study on the methanol extract of
the bulbs of this plant resulted in the isolation of four homoiso-
avanones (50, 58, 59, 61), a chalcone 132 and a tetrahydropyran
derivative 393.42
Veltheimia bracteata Harv. ex Baker is indigenous to South
Africa. The petroleum ether and diethyl ether extracts of bulbs (as
Veltheimia viridifolia) grown from seeds in Berlin have yielded two
homoisoavanones (394 and muscomin, 97)158 as well as a spi-
rocyclic nortriterpenoid 133 and its pentaglycoside 395 from the
petrol and chloroform extracts respectively.159 The homoiso-
avanone 394, was found to exhibit good inhibitory activity
against phosphodiesterase (PDE).158 Compound 394 was found to
inhibit the two PDE-isoenzymes by 70% and 75% at a concen-
tration of 100 mmol l1.158 Veltheimia capensis (L.) DC., native to the
Western Cape, South Africa, has been found to contain an indo-
lizidine alkaloid, steviamine 396. This alkaloid is also present in
Stevia rebaudiana Bertoni (Asteraceae), but such alkaloids have
not yet been isolated from any other Hyacinthaceae taxa.160
Merwilla plumbea (Lindl.) Speta is widely used by southern
African traditional healers. The Zulu use it as a purgative and to
facilitate full term labour. The Sotho eat the cooked bulbs as an
aperient, use bulb decoctions in enemas to treat internal
tumours and for the treatment of lung disease in cattle.
Powdered bulbs are rubbed on sprains and fractures by the
Southern Sotho, while the Tswana believe that bulbs rubbed on
the body will make them resistant to witchcra. The Swati use a
lotion prepared from the bulbs to treat veldsores and boils.161,162
Concern for the sustainability of Merwilla plumbea has led
Ncube et al. to include the bulbs of this plant in a study to
compare the antibacterial, anticandidal and cyclooxygenase
inhibitory activity of the leaves and the, more commonly har-
vested, bulbs of some popular medicinal plants, harvested
during diﬀerent seasons in the year. Antimicrobial activities
between the leaves and bulbs ofMerwilla plumbea were found toThis journal is ª The Royal Society of Chemistry 2013be comparable over all four seasons and as such they concluded
that the leaves could be used in many cases as a substitute for
the bulbs. Likewise both the leaves and bulbs produced good
cyclooxygenase inhibitory activity throughout the year.163,164 A
further study found that in vitro propagation of these plants
could, under the right conditions, result in an increase in the
avonoid and gallotannin levels found in the shoots, which
would allow for the successful mass propagation of these plants
containing elevated levels of the potentially medicinally active
components.110,161 A phytochemical investigation of the bulbs
(as Scilla natalensis Planch.) found two homoisoavanones 62
and 72, seven known eucosterol-type spirocyclic nor-
triterpenoids and the new spirocyclic nortriterpenoids 397, 398
and 399.161 An extract of the lectin-like proteins from the bulbs
of M. plumbea (as Merwilla natalensis Planch.) have been found
to exhibit moderate inhibitory activity (47%) against cyclo-
oxygenase (COX-1).31 In a separate study, the homoiso-
avanones 62 and 400 have been isolated from M. plumbea (as
Scilla natalensis Planch.).162 In addition M. plumbea (as S. nata-
lensis) has been shown to have good in vitro activity against the
parasite Schistosoma haematobium (LC ¼ 0.4 mg ml1).66 Three
homoisoavanones (7, 62, 401) have been isolated from Mer-
willa dracomontana (Hilliard & B.L. Burtt) Speta (as Scilla dra-
comontana Hillard and Burtt).162 A southern African member of
the genusMerwilla, under its basionym Scilla krausii Baker, was
found to contain the homoisoavanone, 80.162
Lachenalia is the largest endemic genus of the Hyacinthaceae
in southern Africa. Surprisingly, very little phytochemical work
has been done on the genus.165 A study of the leaves of Lachenalia
unifolia Jacq. has yielded avone sulphates (luteolin-30-sulphate
and -7,30-disulphate, tricetin-30-sulphate and -7,30disulphate,
diosmetin-30-sulphate and -7,30-disulphate)166 while the bulbs of
L. rubida Jacq., collected from the Western Cape, South Africa,
were found to contain the homoisoavanones 402 and 403.165
The bulbs of Pseudoprospero rmifolium (Baker) Speta have been
found to contain ve 3-hydroxy-3-benzyl-4-chromanone typeNat. Prod. Rep., 2013, 30, 1165–1210 | 1185
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the spirocyclic nortriterpenoid, 15-deoxoeucosterol.167 A subse-
quent study on the bulbs of Pseudoprospero rmifolium subsp.
natalensis J.C. Manning conrmed the previous ndings for the
typical subspecies but, in addition, found the homoisoavanone
59 in the dichloromethane extract.42
Schizocarphus nervosus (Burch.) van der Merwe is widespread in
southern Africa. Although toxic to livestock,1 it plays an important
role in traditional medicine within the region. The bulbs are used
by the Zulu to treat dysentery and nervous conditions in children
as well as treat rheumatic fever.168 In Botswana the bulbs are used
to enhance fertility and to treat infections.169 The methanol extract
of the bulbs of S. nervosus (as Scilla nervosa (Burch.) Jessop) has
been tested for anti-inammatory and anti-microbial activity. The
crude methanol extract displayed a strong, but short-acting eﬀect
on a croton-oil induced contact dermatitis in a mouse ear (66%
reduction of oedema aer 3 h) and the nonpolar components were
active against Staphylococcus aureus (IC50 ¼ 1.8 mg ml1), Kleb-
siellia pneumonia (IC50¼ 2.0 mgml1) andCandida albicans (IC50¼
1.0 mg ml1). Little discrimination was noted between the Gram-
positive and Gram-negative bacteria, but some specicity for the
yeast was observed.169 Five homoisoavanones (49 and 409–412)
and two stilbenoids (413, 414) have been isolated from the
bulbs.168 A further thirteen homoisoavanones (41, 49 and 415–
425) and three stilbenes (414 and 426–427) have been isolated
from the bulbs of S. nervosus (as Scilla nervosa (Burch.) Jessop
subsp. rigidifolia).170,171 Compound 419 was found to be highly
active against colon cancer (HT-29 cell line ED50 ¼ 0.88 mg ml1)
and breast cancer (MDA-MB-435 cell line ED50 ¼ 0.42 mg ml1).170
The yellow inter-bulbscale deposits of this subspecies were like-
wise investigated and eight homoisoavanones were isolated, two
of which were novel (428–429).172 There has been some evidence
presented to indicate that the bulbs may cause damage to liver
cells.173 A homoisoavanone 400 has been isolated from Spetaea
lachenaliioraWetschnig & Pfosser (as Scilla plumbea Lindl.). This
is a little known species, neither toxic nor known to be used by
traditional healers.652 The Urgineoideae
The subfamily Urgineoideae, with more than 100 species,7 has
received considerable taxonomic attention in recent years, with1186 | Nat. Prod. Rep., 2013, 30, 1165–1210widely diﬀering opinions subsequently oﬀered on generic
circumscriptions. Speta recognised eleven genera,174 several of
which have been studied from both a phytochemical and a
pharmacological perspective. More than any other compound
type, the bufadienolides characterise the Urgineoideae. Bufa-
dienolides are C-24 steroids possessing an a-pyrone group
(doubly unsaturated six-membered lactone ring) at position
17b. The presence of these highly toxic cardioactive steroids has
led to these plants being used by man in antiquity, with the
ancient Egyptians reportedly using preparations to treat heart
disease.175 Research into this subfamily was further stimulated
by the sometimes fatal toxicity associated with various species,
both to stock176–178 and to humans.179,180 The systematic position
of the sea onion, Charydbis maritima (L.) Speta, has long been
debated.181 The ancient Greeks referred to the plant as skilla,
the Romans as scilla and for much of the early research on this
plant, the names Urginea maritima or Scilla maritima were
applied. Subsequent work by Pfosser and Speta181 provided
evidence for two genera in the subfamily Urgineoideae in the
Mediterranean region, Urginea Steinh. and Charydbis Speta.
Phytochemical investigations to date support this generic
distinction.
With much of the early research on Charybdis maritima
focused on the plant then known as Scilla maritima, the trivial
names of isolates of this urgineoid accordingly reect this
nomenclatural association. Notably, Scilla is a distinct genus
currently assigned to the subfamily Hyacinthoideae, and has a
very diﬀerent chemical prole. Kopaczewski isolated a toxic
component from the bulbs of C. maritima (as Scilla maritima)
which he termed scillitin.182 It was found to be a diuretic but
the whole extract from the bulbs was found to be more
poisonous to guinea pigs and rabbits than scillitin itself.183 In
contrast, Smith found scillitin to be more toxic to rats than the
crude extract.184 The bufadienolides scillaren A 224, scilliroside
430, proscillaridin A 223 and scillaren F 431 have also been
isolated from C. maritima (reported as Scilla maritima and/or
Urginia maritima).185–190 Using HPLC, with proscillaridin A 223
as a reference, Tittel and Wagner showed the possible presence
of bufadienolides in a plant identied as Scilla rubra L. (here
considered synonymous with C. maritima).191 Petrol extracts of
bulbs of this species (as Scilla maritima and Urginia maritima)
were found to contain fatty acids (lauric acid, myristic acid,This journal is ª The Royal Society of Chemistry 2013
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acid and linolenic acid) and sterols (sitosterol, stigmasterol,
campesterol and cholesterol).192–194
Investigations carried out in the early 1920s focused
primarily on Charydbis maritima (squill). Both the extracts of
fresh bulbs and dried powdered bulbs showed digitalis-like
activity on the heart when tested on frogs and cats.195,196 Mark-
walder196 found no diﬀerence in activity between the fresh and
dried bulbs and noted that neither the dried outer leaves nor
the heart of the bulb exhibited much activity, while the mature
middle layers of the bulb were rich in active components. The
structure of scillaren A 224, the principle active component of C.
maritima (reported as Urginia maritima) was elucidated by Stoll
et al. in 1933.197 The interesting activity shown by the squill
bufadienolides resulted in some comparative studies with
digitoxigenin and strophanthidin as well as the eﬀects of
combination therapy.198,199 Extensive work on the bulbs of C.
maritima (as Urginia maritima) over the following years resulted
in the isolation and identication of a large number and variety
of bufadienolides. They can be divided into those having a
double bond at C-4 (e.g., 224), those having a double bond at C-3
(e.g., 431) and those without either (dihydro C-4) (e.g., 432).
Without exception, within C. maritima they contain a b-hydroxyThis journal is ª The Royal Society of Chemistry 2013group at C-14, a trans junction of rings B and C and a cis junc-
tion of rings C and D. They have been isolated as the aglycones
as well as a variety of glycosides, with scillaren A 224 and pro-
scillaridin A 223 being present in all specimens of C. maritima
investigated. Samples of the plant from across its Mediterra-
nean, European and Middle Eastern range have been investi-
gated and this would account for the great diversity of
bufadienolides isolated.
Von Wartburg and Renz200,201 isolated ve bufadienolides
from C. maritima (as Urginia maritima), scilliroside 430,
scillaren A 224, scillaren F 431, proscillaridin A 223 and
scillarenin-b-D-glucopyranoside 433. The structures reported at
that time were subsequently revised and the structures shown
here reect that revision.202,203 Gorlich204 found proscillaridin A
223, scillaren A 224, scilliglaucoside (scillaren F) 431 and
scillicyanoside 434 in crystalline form as well as minor
amounts of scillicoeloside (no structure given) and glucoscillaren
A 435. Later work on this plant resulted in the isolation of
further minor components, scilliphaeoside 436 and glucoscilli-
phaeoside 437.205 A reinvestigation of the bulbs of C. maritima (as
Urginia maritima) in 1991 by Krenn et al.206 resulted in an addi-
tional four new bufadienolides, identied as 5a-4,5-dihy-
droproscillaridin A 432, 5a-4,5-dihydroglucoscillaren A 438,Nat. Prod. Rep., 2013, 30, 1165–1210 | 1187
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and 19-oxo-5a-4,5-dihydroproscillaridin A 440. Forty-one bufadie-
nolides were isolated from an Egyptian sample of C. maritima (as
Urginia maritima).207 Proscillaridin A 223, scillaren A 224 and
scilliroside 430 were found as expected. In addition to 15 known
bufadienolides found (223, 224, 430, 434, 435, 436, 441–449), 10
new glucosides of known aglycones (450–459) and sixteen new
compounds were isolated (460–475). An unusual 9-hydroxy bufa-
dienolide 476 was later isolated, also from Egyptian material.2081188 | Nat. Prod. Rep., 2013, 30, 1165–1210From 2000 until 2012 a total of eleven additional new bufadie-
nolides (477–487) have been isolated from C. maritima (as Urginia
maritima). Two of the compounds 477 and 478 were isolated from
Spanish material209 and nine (479–487) from a plant cultivated in
Japan (provenance undisclosed).210 A comparative study of the
bulbs of C. maritima collected in the northern and southern
regions of the Mediterranean area showed some diﬀerences in
both the quantity and type of bufadienolides isolated.211
Both samples contained scilliroside 430, scillareninThis journal is ª The Royal Society of Chemistry 2013
Review NPR3-O-b-D-glucopyranoside 433, proscillaren A 223, scilliphaesidin 3-
b-D-glucopyranoside 441, scilliglaucoside 431, scilliphaoside 436
and 12-epi-scilliphaeoside. In addition, the bulbs from Tunisia
contained glucoscilliphaeoside 437, 12-epi-glucoscilliphaeoside,
12b-hydroxyscilliglaucosidin 3-O-b-D-glucopyranoside 488, 12-epi-
scilliphaeosidin 3-O-b-D-glucopyranoside 443 and 12-epi-scilli-
phaeosidin 3-O-a-L-rhamnopyranosyl-a-L-rhamnopyrano- side 489.
Bulbs sourced from Sardegna also contained gamabufotalin 3-O-a-
L-rhamnopyranoside 490, scillirubrosidin 3-O-a-L-rhamnopyrano-
side 491, scillirubroside 492, 12b-hydroxyscilliroside 446, 5a-4,5-
dihydroscillirosidin 3-O-a-L-thevetopyranosyl-b-D-glucopyranoside
475, deacetylscilliroside 443, 10-carboxy-5b-14b-hydroxybufa-
3,20,22-trienolide 5-O-b-D-glucopyranoside 493 and scilliglaucoge-
nin 494.
The avonoid, anthocyanin and sterol content of the bulbs
of C. maritima (as Urginia maritima) have been investigated. TheThis journal is ª The Royal Society of Chemistry 2013ethanol extract of the bulbs was studied by gas-liquid chroma-
tography and the sterols identied by comparison to known
reference compounds. Sitosterol, stigmasterol, campesterol,
cholesterol, D5-avenasterol and D7-avenasterol were found to be
present.193,194 Red bulbs of C. maritima (as Urginia maritima),
collected in the Balearic Islands contained cyanidin 495, cya-
nidin-3-monoglucoside 496 and pelargonidin-3-monoglucoside
497, both in the free form and acylated with p-coumaric
acid.212–216 The proportion of anthocyanin was found to be
higher in tetraploids than in triploids or hexaploids.217
The avonoids isolated included kaempferol-7-O-b-D-gluco-
pyranoside-3-O-b-D-triglucopyranoside 498, kaempferol-7-O-b-D-
glucopyranoside-3-O-a-L-rhamnopyranosyl-b-D-glucopyranoside
499, kaempferol-7-O-b-D-glucopyranoside-3-O-b-D-diglucopyr-
anoside 500 and kaempferol-7-O-a-L-rhamnopyranoside-3-O-a-
L-rhamnosyl-b-D-glucopyranoside 501.218 In addition theNat. Prod. Rep., 2013, 30, 1165–1210 | 1189
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glycosylavones have been isolated from the ethyl acetate
extract of the bulbs. They have been identied as vitexin 506,
isovitexin 507, orientin 508, isoorientin 509, scoparin 510 and
isoscoparin 511.220–223 Fernandez et al. identied twenty-ve
avonoids in a Spanish sample of C. maritima bulbs (as Urginia
maritima). They followed a parallel series: pelargonidin,
kaempferol, cyaniding, quercetin and taxifolin. A complex
mixture of both C- and O-glycosides was obtained.224 A fructan,
sinistrin, has been isolated from C. maritima (as Urginia mar-
itima) and found to be a mixed type b-D-fructan, with (2–1)
linked and (2–6) linked unbranched b-D-fructofuranosyl and a-
D-glucopyranoside residues.225,226
C. maritima (reported as Urginia maritima) has been used as a
form of rodenticide since the 13th century.202 The toxic
component has been found to be scilliroside 430, which aﬀects
the cardiovascular and central nervous systems, resulting in
death.202 Scilliroside has an emetic eﬀect on humans, cats, dogs
and pigeons, but rats and mice are unable to vomit and as such
they die within a few hours of ingesting the bulbs. The avonoid1190 | Nat. Prod. Rep., 2013, 30, 1165–1210fraction has been found to have a diuretic eﬀect227 and the
ethanolic extract of Spanish squill has shown good insecticidal
activity against the stored grain pest Tribolium castaneum (red
our beetle).228 Twelve wild populations of the bulbs were
studied with the red bulbs giving 60–90%mortality if applied at
20–30 mg insect1.228 An extract of the bulbs of C. maritima (as
Urginia maritima) growing in Turkey has been found to exhibit
greater toxicity than cisplatin against the A549 non-small cell
lung cancer (NSCLC) cell line.229 Tissue cultures of C. maritima
(as Urginia maritima) grown both in the dark and under light
showed no sign of the bufadienolides commonly associated
with this species. The cultures grown in the light did though
produce anthocyanins.230
The range of bufadienolides found in the bulbs of Charybdis
hesperia (Webb & Berthel.) Speta (as Urginea hesperia Webb &
Berthel.) indicates a close relationship to C. maritima. Thirteen
bufadienolides have been isolated including scillarenin (512)
and a variety of associated glycosides.231 Urginea fugax (Moris)
Steinh. is a species which is widespread in the Mediterranean
area. In contrast to C. maritima and C. hesperia, cardenolidesThis journal is ª The Royal Society of Chemistry 2013
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fugaxin 513 has a rubellin-like carbohydrate linkage between C-
3 and C-2, unlike any seen in C. maritima and C. hesperia, which
lends chemotaxonomic support to recognition of both Urginea
and Charybdis in the Mediterranean region.181 Six bufadie-
noides have been isolated from the bulbs of Charybdis pancra-
tion (Steinh.) Speta (as Urginea pancration), scilliglaucoside 431,
scillirubroside 492, scilliroside 430, 5a-4,5-dihydroscillirosidin
3-O-a-L-thevetopyranosyl-b-D-glucopyranoside 475, arenobufa-
gin-3b-O-L-rhamnopyranosyl-40-b-D-glucopyranoside 514 and
the glycoside 515.233,234 Charybdis aphylla (Forssk.) Speta (as
Urginea aphylla (Forssk.) Speta), growing in the northeastern
Mediterranean region was found to contain eleven bufadieno-
lides, scillicyanoside 434, gamabufotalin-3-O-a-L-rhamnopyr-
anoside 490, scilliglaucoside 431, gamabufotalin-3-O-a-L-
rhamnosyl-b-D-glucopyranoside 439, proscillaridin A 223, scil-
liphaeosidin-3-O-b-D-glucopyranoside 437, scillarenin-3-O-b-D-
glucopyranoside 433, 16b-O-acetylgamabufotalin-3-O-a-L-rham-
nopyranoside (16b-O-acetyl 436), 12b-hydroxyscilliroside 446
and 5a-4,5-dihydroxyscillirosidin-3-O-a-L-thevetopyranosyl-b-D-
glucopyranosyl-b-D-glucopyranoside (475 glucoside).235 The
similarity in chemical composition of the bulbs of Charybdis
from across the European region highlights their close
relationship.
As early as 1923, Juritz reported the presence of a glucoside
in the toxic South Africa plant Boosia macrocentra (Baker) Speta
(as Urginea macrocentra Baker) with digitalis-like activity and he
noted that it could be used as a substitute for squill.236 This
plant has also been implicated in stock mortality and it is used
by the Zulu as a vermifuge (as Drimia macrocentra).237 The major
component was identied as rubellin 516 by NMRThis journal is ª The Royal Society of Chemistry 2013spectroscopy.237 In 1927, work by Watt238 on South African
Sekanama burkei (Baker) Speta (as Urginea burkei), yielded two
glucosides, a red compound found to be toxic to animals and
having a digitalis-like eﬀect on the heart as well as a diuretic
eﬀect, and a white compound which resulted in paralysis of the
central nervous system and respiration. Additional work on S.
burkei (as Urginea burkei) and Urgineopsis modesta (Baker) Speta
(as Urginea rubella Baker) in the 1940s and 1950s resulted in the
isolation and identication of two cardiac glycosides, trans-
vaalin and rubellin 516 respectively.239–243 Rubellin 516 was
found to behave as a cardiac poison towards rats while trans-
vaalin was found to kill rats primarily by its eﬀect on the central
nervous system.241,243,244 Rubellin was found to have a digitalis-
like action on cats.245 Further work by Louw et al.246 on trans-
vaalin led to the conclusion that it was either isomeric with
scillaren A 224 or a stable complex of scillaren A 224 and scil-
liroside 430. This was based on melting point analysis, toxicity
tests and the fact that hydrolysis of transvaalin led to the same
products as the hydrolysis of scillaren A, namely scillaridin A
517 and scillabiose (disaccharide). Zoller and Tamm247 and
Tschesehe and Hottemann240 all concluded that transvaalin and
scillaren A were identical compounds. The structure of rubellin
516was fully elucidated by Steyn et al. in 1986248 using high-eld
NMR spectroscopy. Later work by Krenn et al.249 on Sekanama
sanguinea (Schinz) Speta (as Urginea sanguinea Schinz) yielded
eight bufadienolides as well as a steroidal sapogenin and stig-
masterol. The rst six bufadienolides, namely scillirosidin 518,
deacetylscillirosiden 519, 12b-hydroxyscillirosidin 445, 12b-
hydroxydeacetylscillirosidin 520, 12b-hydroxyscilliroside 446
and 5a-4,5-dihydro-12b-hydroxyscillirosidin 521 had been iso-
lated previously from other members of the Urgineoideae. TwoNat. Prod. Rep., 2013, 30, 1165–1210 | 1191
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hydroxyscillirubrosidin-3-one 523 were identied using NMR
spectroscopy. The steroidal saponin, 7b,15a-dihydrox-
yyamogenin 524 was the rst such compound to be isolated
from a member of the Urgineoideae. Majinda et al.250 investi-
gated another specimen of the same plant, and found stig-
masterol, phloroglucinol 525, phloroglucinol 1-b-O-
glucopyranoside, scillaren A 224 and the novel 5a-4,5-dihy-
droscillaren A. In addition, salicylic acid and 3-hydroxy-4-
methylbenzoic acid were isolated. An ethnopharmacological
study of S. sanguinea, using patient records from Ga-Rankuwa
Hospital in South Africa revealed a number of cases of
poisoning as a result of ingestion. The amount usually
prescribed by traditional healers does not result in adverse side
eﬀects, but the patients admitted to the hospital had taken
more than the prescribed dose. A brine shrimp assay showed a
seasonal variation in toxicity, with the plant being more toxic in
February (late Summer) than in September (Spring).251 Seka-
nama sanguinea has traditionally been used for many diﬀerent
conditions, including asthma and it is oen taken by pregnant
women. A study by Marx et al.252 (as Urginea sanguinea) showed
signicant damage to chick embryos aer exposure to this
plant. They concluded that it should be used with extreme care
by traditional healers.253 Undoubtedly the bufadienolides
dominate the chemistry of the Urgineoideae, including the
Sekanama species. However, the isolation of a novel homoiso-
avanoid from the bulbs of Sekanama delagoensis (Baker) Speta
(as Drimia delagoensis (Baker) Jessop) indicates that a broader
range of secondary metabolites can be expected, if not
commonly found.254 The homoisoavonoid 526 and 3-methoxy-
4-hydroxybenzoic acid 527, were isolated from the dichloro-
methane and methanol extracts of the bulbs respectively.254
Other sub-Saharan members of the Urgineoideae to receive
attention include Urginavia altissima (L.f.) Speta (as Urginea
altissima (L.f.) Baker and Drimia altissima (L.f.) Baker), Fusilum
physodes (Jacq.) Raf. ex Speta (as Urginea physodes (Jacq.) Baker),1192 | Nat. Prod. Rep., 2013, 30, 1165–1210Urginavia epigea (R.A.Dyer) Speta (as Urginea epigea R.A.Dyer),
Urginea lydenburgensis R.A.Dyer and Urginea riparia Baker.
Characteristic bufadienolides have been isolated and identied,
many of which include either an aldehyde group at C-10 or a
rubellin type carbohydrate group doubly linked to the aglycone at
positions 2a and 3b. The best known of this group is the wide-
spread Urginavia altissima (oen referred to as Drimia altissima or
Urginea altissima). Rat populations need to be controlled to limit
threats to public health and minimise crop damage. The toxicity
of U. altissima has been investigated with respect to the eld rat,
Arvicanthis abyssinicus.255 Synthetic rodenticides aﬀect non-target
species and can be expensive. The powdered bulb was tested and
found to be toxic at levels of 5% of the daily food intake. If the
percentage was lower, no mortality was noted. Urginavia bra-
chystachys (Baker) Speta has (as Drimia brachystachys (Baker)
Stedje) reportedly been used as an arrow poison.256
Both bufadienolides and alkaloids have been isolated from U.
altissima. The alkaloids, lycorine 528 and acetylcaranine 529 have
not been found by any subsequent investigators and the identity
of the plant investigated by Miyakado and co-workers257 has been
called into question as bulbs of U. altissima may be easily
confusedwith those of some Amaryllidaceae, especially the genus
Crinum L.258,259 Six bufadienolides have been isolated from U.
altissima collected in Kenya, all of which have an aldehyde at C-10
(530–535).260,261 A South African sample of this plant was found to
contain 12b-hydroxyscillirosidin 445,258 which has been isolated
from S. sanguinea previously and urginin 536 with an interesting
trisaccharide substituent at C-3.258 A specimen from Ethiopia
yielded diﬀerent bufadienolides again, gamabufotalin-3-O-a-L-
rhamnopyranoside 490 and arenobufagin-3-O-a-L-rhamnopyr-
anoside 537.259 It would appear that signicant regional diﬀer-
ences exist in the type of bufadienolide found in U. altissima. U.
altissima is widely used for the treatment of gout, rheumatism
and a number of respiratory conditions, including asthma.258
This plant is also used by Zimbabwean traditional healers to treat
skin conditions. It has been found to produce a mildThis journal is ª The Royal Society of Chemistry 2013
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been found to be due to the presence of calcium oxalate raphides
in the bulbs and as such the appropriateness of its use as a skin
treatment has been questioned.262
Fusilum physodes (asUrginea physodes (Jacq.) Baker) was found
to contain four bufadienolides, physodines A 538, B 539, C 540
and D 541. Two of which, physodines A and B, both having a C-10
aldehyde group, were found to be toxic to weaned guinea pigs
(fractions not causing death in 48 h at 200 mg kg1 were consid-
ered non toxic). Physodines C and D were of interest in that they
were the rst naturally occurring 14-deoxybufadienolides to be
isolated.263 An ethanolic extract of the bulbs has been shown to
have antifungal activity.264 The methanol extract of the bulbs of
Fusilum depressum (Baker) U.Mu¨ll.-Doblies J.S.Tang & D.Mu¨ll.-
Doblies (as Drimia depressa (Baker) Jessop) was found to contain
two bufadienolides, 542 and 543.265 The leaves of this plant are
toxic to cattle, sheep and rabbits and the plants are used by the
Sotho as a good luck charm or to cause harm to one's enemy.265
Novel rubellin type bufadienolides, riparianin 544 and lydenbur-
genin 545, have been isolated from Urginea riparia and Urginea
lydenburgensis R.A.Dyer respectively.237,266 In addition, Urginea
lydenburgensis was found to contain the novel bufadienolide,
scillicyanosidin 546, with an aldehyde group at C-10. Riparianin
544 showed moderate activity against MCF7 (breast), TK10 (renal)
andUACC62 (melanoma) cell lines (total growth inhibition of <3.5,
<7 and <10.5 ppm respectively). Urginavia epigea is used locally to
treat backaches or as a soap. The smoke from smouldering bulbs
is also used as a treatment for headaches and colds.267 In addition
to the buadienolide 517,268 two eudesmane sesquiterpenoids were
isolated, 547 and 548. These were the rst to be reported from the
Hyacinthaceae and due to their occurrence in U. epigea but not the
o-confused U. altissima, provide species level taxonomic
markers.267 The bufadienolide 517, has an unusual 3,5-diene
system, readily obtained synthetically, but not commonly isolated
directly from plant sources.268 The butanol extract of the bulbs of
U. epigea was found to have signicant molluscicidal activity
against the bilharzia-carrying snail, Bulinus africanus. This result
has raised some concern with regards its use as soap and the
potential toxic aﬀect it may have on other aquatic biota.269
An Indian member of the Urgineoideae, known locally as
‘jungli-piyaz’ or ‘bhuikanda’ and Indian squill has been usedThis journal is ª The Royal Society of Chemistry 2013traditionally for stomach complaints, as a cardiac stimulant, a
diuretic, as well as to treat asthma, cough or bronchitis and
various infections.270 Commercially available samples vary with
some plants having a truncated bulb and others a scaly bulb.271
For much of the work reported, the plant has been identied as
Urginea indica (Roxb.) Kunth or Scilla indica Baker. The name
Indurgia indica (Roxb.) Speta is currently accepted. Extracts of
the bulbs have shown some activity against Neisseria gonor-
rhoeae infections272 and have had outstanding antimicrobial
activity attributed to them in a survey of medicinally used plants
in India.273 The ethanolic extract of the bulbs of I. indica (as
Scilla indica Baker) has been found to have good antioxidant
activity (protection against lipid peroxidation induced by
ferrous sulphate in a dose-dependant manner, with 49%
protection for hydroxyl radical-mediated hydroxylation at a
concentration of 250 mg ml1) as well as to possess cardiac
activity on a par with ouabain.271,274 Rao and Rangaswami have
detected bufadienolides in extracts of the bulbs of I. indica (as
Scilla indica Roxb.) and have isolated scillaren A 224 as the
principle active component.275,276 Jha and Sen, however, found
no trace of scillaren A 224 in a plant identied as Scilla indica at
the time.277 The principle bufadienolides isolated from this
plant (as Urginia indica Kunth) by various investigators are
scillaren A 224 and proscillaridin A 223,275,278–281 with scillaren A
being reported as early as 1956. These are also the principle
bufadienolides of the European squill C. maritima. In small
doses, the action of I. indica is the same as C. maritima, in that it
slows the heart beat and increases urine ow and it can
successfully be used as a substitute for C. maritima.282 Jha and
Sen278,280 have studied the twelve diﬀerent cytotypes of I. indica
(as Urginea indica), belonging to four ploidy levels. Scillaren A
224 and proscillaridin A 223 were present in all twelve. Bulbs
were investigated through three successive years. The tetra-
ploids showed the highest concentration of these bufadieno-
lides, followed by diploids and then triploids. Signicant
variation in the bufadienolide concentration was also noted
between samples collected in northern and southern India, with
the northern samples showing much lower levels of proscillar-
idin A 223 and scillaren A 224.283 In addition, two minor
components, scilliphaeoside 436 and anhydroscilliphaeosidin,
were found to be present in the tetraploid cytotypes andNat. Prod. Rep., 2013, 30, 1165–1210 | 1193
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was investigated with only minor diﬀerences noted between the
ploidy levels. Stigmasterol predominated, with sitosterol and
campesterol being found in the tetraploid cytotypes and some
of the triploids respectively.284,285 Kopp and Danner281 found the
bulbs of I. indica (as Urginia indica) to contain six bufadieno-
lides, scillarenin 512, proscillaren A 223, scillarenin A 224,
scilliphaeosidin 3-O-a-L-rhamnopyranoside 549, scilliglaucosi-
din 3-O-a-L-rhamnopyranoside 534 and scilliglaucosidin 3-O-b-
D-glucopyranoside 535, while Saxena and Chaturvedi isolated 6-
desacetoxy scillirosidin 550.286 In addition to the bufadienolides
and sterols, Sultana et al. have isolated three novel avonoid
glycosides (551–553) from bulbs collected in Bangladesh.287
Seasonal variation in the glycosidal content of the bulbs has
been observed with the highest such levels found during
October at the onset of dormancy. The levels steadily decrease
to reach aminimum in June.288 Sterol content has been found to
peak during the pre-owering and pre-vegetative growth stages
and it has been suggested that the sterols could be a trigger for
the onset of reproductive and vegetative growth in the
species.289 Signicant antifungal activity has been noted and
attributed to the presence of a 29-kDa glycoprotein which
inhibited growth of Fusarium oxysporum at a concentration of 10
mg protein well1.290,291 This protein has in addition shown good
antitumour activity against the growth of an ascites tumour and
mouse mammary carcinoma (tested in vivo using 6–8 week old
female mice).292 The bulbs of I. indica (as Urginia indica L.)
collected in Nigeria were found to contain six alkylresorcinols of
the structure types shown in 554 and 555.293 An ethanolic extract
of I. indica (as Scilla indica), has reportedly shown good1194 | Nat. Prod. Rep., 2013, 30, 1165–1210inhibition of the Semliki Forest Virus and the active principal
found to be a diosgenin saponin.294
The genus Drimia Jacq. is closely related to Urginea. Drimia
robusta Baker is widely used in southern Africa by traditional
healers. It has been used as a diuretic, as a treatment for
feverish colds, to promote the healing of broken bones, to treat
diseases of the uterus and to relieve stabbing pains in the
chest.258,295 Luyt et al.295 investigated the biological activity of
this plant in order to substantiate its use in traditional medi-
cine. Anti-bacterial activity was found to be present in the ethyl
acetate extract of the bulbs. An ethanolic extract of the bulbs
showed higher inhibitory activity than indomethacin in the
screening for inhibition of cyclooxygenase. This inhibition of
prostaglandin synthesis (tested for with the cyclooxygenase
assay) could explain the plant's use as a treatment for
feverish colds. Further work on the COX-1 inhibition of a water
extract of the bulbs showed activity above 70%.264 Evidence for
the presence of proscillaridin A 223 was presented: TLC
and NMR data were compared with a standard sample. Luyt
et al.296 then compared bulbs derived from tissue culture with
those grown naturally. A standard proscillaridin A 223 was
used for comparison and the UV spectra and qualitative TLC
results were compared. The results indicated that the bufa-
dienolide content was the same in the in vitro-derived plants as
in those grown naturally. This is in contrast to the work done
on C. maritima, where no bufadienolides were found in the
tissue cultured bulbs.230 Phytochemical studies of the bulbs of
D. robusta yielded eight bufadienolides, 12b-hydroxyscillir-
osidin 445, 6b-acetoxy-3b,8b,14b-trihydroxy-12-oxobufa-4,20,22-
trienolide 556, scilliroside 430, 12b-hydroxyscilliroside 446,
hellebrigenin-3-O-b-glucopyranoside 531, 16b-hydroxyhelle-
brigenin 557, 16b-hydroxyhellebrigenin-3-O-b-glucopyranoside
558 and 5b,16b-dihydroxybufalin-3-O-b-glucopyranoside 559 as
well as three common aromatic acids, 4-hydroxy-3-methox-
ybenzoic acid, 3,4-dihydroxybenzoic acid and trans-3-(40-
hydroxyphenyl)-2-propenoic acid.258,268,297 The toxicity of Rho-
docodon madagascariensis Baker, a plant endemic to Mada-
gascar, has been tested against the embryo-larvae of medaka
sh (Oryzias latipes) and an LD50 of 1 mg ml
1 was
established.298
Work on the genus Bowiea Harv. ex Hook.f. has centred on
Bowiea volubilisHarv. ex Hook.f. Most of the investigations were
carried out in the 1950s and early 1960s. This African species isThis journal is ª The Royal Society of Chemistry 2013
Review NPRtoxic and as early as 1938, the presence of a cardioactive
glucoside was reported.299 Katz and Tschesche et al. have
between them reported the presence of several bufadienolides
(bovisides A 560, B, C, D, bovogenin E, bowieasubstanz G, glu-
cobovoside A 561, nabogenin (scilliglaucosidin) 532, bovor-
uboside 562 and bovogenin A 563) between the years of 1950
and 1959.300–314 Structures have been reported for nabogenin
532, bovoruboside 562, bovoside A 560, glucobovoside A 561
and bovogenin A 563, although the structure reported for
bovoruboside is not certain. The cardioactive glycosides from B.
volubilis attracted much attention in the early years of their
discovery. The activity was initially found to be in the region of
strophanthin,315 the action was as rapid and lasting with a
cumulative eﬀect, though not as much as digitoxin.316–318 Solu-
tions of bovoside A were found to be unstable, due to the
aldehyde group at C-19 being vulnerable to oxidation. Reduc-
tion of this group to the alcohol (bovosidol A) gave a stable
solution which could then be assessed for activity.319,320 Material
from East Africa (as Bowiea kilimandscharica Mildbr.) was
initially reported to contain two bufadienolides, kilimanschar-
ogenins A and B. Katz concluded that kilimanscharogenin A
was the same compound as bovogenin A 563.321
Chen and Henderson322,323 carried out a comparative survey of
the cardioactivity of twenty-nine bufadienolides and cardenolides
from various sources. Included in the survey were bufadienolides
from B. volubilis. The tests were carried out on etherised cats by
slow continuous intravenous injection and the electrocardiograms
were recorded to conrm the digitalis-like action of these
compounds. The potency of each compound was determined in
terms of lethal dose (LD), the amount (mg kg1) needed to kill a
cat of approximately 2 kg in 30–60 min. The bufadienolides were
found to be more potent than the cardenolides, with the glyco-
sides seldom showing more activity than the aglycones. The
methyl C-10 analogues were less active than the compounds with
an aldehyde group in the C-10 position and 3-epimerisation and
5a-conguration reduced the activity. A later study by Chen
increased the number of cardenolides and bufadienolides to y
and similar proles were obtained using the same assay system.3243 The Ornithogaloideae
The Ornithogaloideae are widespread throughout Africa,
Europe and southwest Asia. This group consists of approxi-
mately 280 species,5 with a recent phylogenetic analysis byThis journal is ª The Royal Society of Chemistry 2013Mart´ınez-Azor´ın et al.6 recognising nineteen monophyletic
genera. Phytochemical studies on the Ornithogaloideae have
centred on Ornithogalum L. and Galtonia Decne., primarily
driven by the signicant biological activity attributed to the
compounds isolated. In addition, a small amount of work has
been done on Albuca L., Eliokarmos Raf., Stellarioides Medik.,
Loncomelos Raf. and Honorius Gray. The types of compounds
isolated are strongly linked to the geographic region the plant
species derive from, with the African taxa containing primarily
cholestane glycosides and spirosterols, and the European taxa
cardenolides. Some avonoids and sterols have been isolated
from plants sourced from all regions studied. Additionally, a
limited number of homoisoavanones have been identied
from the bulbs.
The genus Albuca L. is widespread in southern Africa, with
some species occurring in the Arabian Peninsula. The bulbs of
Albuca fastigiata Dryand. have been investigated and only one
compound was isolated, a homoisoavonoid, 564.325 Albuca
fastigiata is found on the East coast of South Africa and is used
by the Zulu as a protective charm and to treat malicious food
poisoning.325 Another southern African species, Albuca setosa
Jacq., has been tested for anti-inammatory activity in a carra-
geenan-induced rat paw edema assay.326 This plant is used by
traditional healers to treat wounds, among other conditions,
and was found to signicantly inhibit carrageenan-induced paw
edema for a 3-hour challenge (43–55% over 3 h at 150 mg kg1
and 68–85% for 300 mg kg1). Albuca setosa has also been used
by traditional healers in the Nkonkobe municipality in South
Africa for the treatment of diabetes.327 As part of a study on the
steroidal saponins of various monocot families, Okanishi
et al.328 found Albuca nelsonii N.E.Br. to contain ruscogenin 565.
This was identied by comparison of melting points, mixed
melting points, optical rotations, infrared and mass spectra
with an authentic sample.
Galtonia candicans (Baker) Decne. is native to South Africa,
and was investigated by the laboratories of Kuroda and Mim-
aki329–333 who used bioassay-directed fractionation to isolate the
active components of the bulbs. The methanol extract was found
to be active against leukemia HL-60 cells (IC50 ¼ 0.017 mM). This
was further partitioned between n-butanol and water, with the
activity being retained in the n-butanol fraction (IC50 ¼ 0.0056
mM). This was found to contain the hexacyclic rearranged cho-
lestane diglycoside, candicanoside A 566, the polyoxygenated 5b-
cholestane diglycoside galtonioside A 567, six cholestaneNat. Prod. Rep., 2013, 30, 1165–1210 | 1195
NPR Reviewbisdesmosides 568–573 and six cholestane glycosides 574–
579.329–333 Candicanoside A 566 and galtonioside A 567 were
found to have potent activity against leukemia HL-60 cells (IC50¼
0.032 mM and 0.057 mM respectively) and further testing on a 38
cell line assay showed diﬀerential cytotoxicities against breast
cancer, CNS cancer and lung cancer lines, while colon cancer,
ovarian cancer and stomach cancer cell lines were resistant to
them.330,331 Compound 569 showed moderate activity against
leukemia HL-60 cell lines ((IC50 ¼ 6.8 mM)332 and compounds
575–578 showed good activity using the same assay (IC50 ¼
0.00012 mM, 0.00048 mM, 0.0024 mM and 0.053 mM respec-
tively).333 Tang and Yu have achieved the total synthesis of can-
dicanoside A 566, using a 27-step synthesis.334,335 Another
southern African species of Galtonia that has received some
attention isGaltonia princeps (Baker) Decne.336 Amethanol extract
of the bulbs yielded the cholestane derivative 580. Both the bulbs
and aerial leaves of Galtonia viridiora I.Verd. were found to
contain monoglycosides of caﬀeic acid, principally rhamnose
and glucose.337
Work on the bulbs of Galtonia saundersiae (Baker) Mart.-
Azor´ın, M.B.Crespo & Juan (as Ornithogalum saundersiae), a
native of the East coast of South Africa, began in the early 1990s
with the isolation of three acylated cholestane glycosides 581–
583. All three were examined for their inhibitory eﬀect on cyclic
AMP phosphodiesterase. Compounds 582 and 583 showed good
activity (IC50 ¼ 0.00025 mM and 0.00020 mM respectively), sug-
gesting that the presence of a benzoyl group attached to the
sugar moiety is essential for activity.338 Six additional cholestane1196 | Nat. Prod. Rep., 2013, 30, 1165–1210glycosides 584–589 were isolated and tested for their inhibitory
activity on cyclic AMP phosphodiesterase. Compounds 585 and
588, with the acyl group at the C-3 hydroxyl position of the
rhamnose group, showed good activity (IC50 ¼ 9.9  105 mM
and 10.9  105 mM respectively), as did compound 589 (40%
inhibition at 0.08 mg ml1), while the other compounds were
inactive.339,340 Compound 590, isolated from the bulbs of G.
saundersiae (as Ornithogalum saundersiae), showed signicant
inhibition (IC50 ¼ 3.1 mM) of the proliferation of peripheral
blood lymphocytes produced by a patient with chronic renal
failure, suggesting potential as an immunosuppressive agent.
Rearranged cholestane glycosides (591–599) with a six-
membered hemiacetal ring E, between C-16 and C-23, have been
isolated. The conformation of ring E was determined through
molecular mechanics and molecular dynamics calculations.341
These compounds were tested for anti-tumour activity,
primarily against leukaemia HL-60 cells and MOLT-4 cells.
Compounds 591 (IC50 ¼ 21.0 nM and 18.0 nM), 592 (IC50 ¼ 9.2
nM and 3.2 nM) and 597–599 (IC50 ¼ 0.019, 0.063 and 0.052 mM
for HL-60 cells) showed signicant cytotoxic activity, primarily
through the induction of apoptosis. These results would indi-
cate that the presence of an aromatic ester group at the glyco-
side moiety is essential for good activity.342–348 Further
investigation of themethanol extract of the bulbs resulted in the
isolated of the related cholestane glycoside 600.349 In addition to
the rearranged cholestane glycosides mentioned above, ten new
(575, 601–609) and three previously isolated (567–569) choles-
tane glycosides, with a glycosidic moiety at C-16 have beenThis journal is ª The Royal Society of Chemistry 2013
Review NPRtested for their inhibitory activity against leukemia HL-60 cells
and MOLT-4 cells. All these compounds showed signicant
activity, with a loss of activity noted each time the ester group on
the sugar moiety was removed.350–353 Due to the signicant anti-This journal is ª The Royal Society of Chemistry 2013tumour activity shown by these plant extracts, a number of
patents have been led in Japan and China covering the extract
methods used, the use of the saponins and, in some cases, the
synthesis of the active components.354–358 In particular, 567Nat. Prod. Rep., 2013, 30, 1165–1210 | 1197
NPR Review(called OSW1) has been the subject of much synthetic work. The
full synthesis of the compound itself has been accomplished,
and a large number of analogues have been produced for
structure–activity relationship studies. Studies indicate that
OSW1 acts by damaging the mitochondria and inducing
apoptosis through an increase of cytosolic calcium and thus the
activation of calcium dependent apoptosis. It has been
demonstrated that OSW1 is active against some cells that are
resistant to conventional anti-cancer agents, in particular u-
darabine-resistant chronic lymphocytic leukemia cells.359 In
addition to the work on the anti-tumour activity of G. saunder-
siae, the ethanol extract of the whole dried plant has been tested
for its protective eﬀects against acute hepatic failure. The
authors concluded that it did provide some benet, primarily
through suppressing oxidative stress, lipid peroxidation and
apoptosis of hepatocytes, as well as reducing
inammation.360,361
Species from the genus Ornithogalum have received
substantial attention. While early work on the genus began in
the 1950s on the European members of the genus, later work
has included species from Turkey and Iran.
Work on the European species of Ornithogalum was initially
centred on Ornithogalum umbellatum L. (common Star of Beth-
lehem). European species of Ornithogalum are characterised by
the presence of cardenolides, with some avonoids also identi-
ed. Extracts of the bulbs of O. umbellatum were found to have a
digitalis-like eﬀect on frog, rabbit and cat hearts. In all cases, a
positive inotropic action was noted, decreased conduction and
nally systolic standstill.362–364 A clinical trial found that when
tablets of O. umbellatum were substituted for digitoxin there was
a loss of activity and uid retention increased. When the tablets
were coated to protect them from stomach acid, the digitalis-like
action was re-established but at only half the expected strength. It
was concluded that only half the active components were being
absorbed. When compared to digitoxin, the drug showed less
slowing of the heart, a greater diuretic eﬀect and less gastroin-
testinal nausea.365 The principal active component of O. umbel-
latum was found to be the cardenolide convallatoxin 610.366 The
cytotoxicity of convallatoxin 610was studied. It was found to have
an IC50 of 002 mg ml
1 when assayed against Eagle's KB strain of
human carcinoma and structure–activity studies showed that the
glycosidic portion was essential for activity and that the b-hydroxy
groups at C-5 and C-14 and the aldehyde at C-10 signicantly
enhanced the activity.367 The convallatoxin 610 content in the
bulbs can be increased by deoration of the plant.368 In total,
sixteen cardenolides (610–626) have been isolated from the bulbs
of O. umbellatum L.366,369–371 Later phytochemical investigations of
the bulbs resulted in the isolation and identication of two
avonoids (627 and 628)372 while the four avonoids (627–630)
were isolated from the leaves.372,373 Compounds 629 and 630were
also isolated from the leaves of Ornithogalum algeriense Boiss.
and Ornithogalum kochii Parl.373 Sabudak and Oyman reported
the presence of 3-O-(20-methoxy-40-(2-pentenal))-phenylsitosterol
in the bulbs ofO. umbellatum374 and a study of the roots colonized
by the fungus Glomus intraradices found a complex range of
apocarotenoids.375 A range of cardenolides have been isolated
from the species Loncomelos magnum (Krasch. & Schischk.) Speta1198 | Nat. Prod. Rep., 2013, 30, 1165–1210(as Ornithogalum magnum) (610, 614, 631–635),376–382 Honorius
nutans (L.) Gray (as Ornithogalum nutans) (610, 631, 632,
636–664),383,384 Ornithogalum gussonei Ten. (631, 635, 665)385 and
Honorius boucheanum (Kunth) Holub (as Ornithogalum bouchea-
num) (666–673).386 The aerial parts of O. gussonei yielded two
avonoids saponaretin 674 and saponarin 675.387 A terpene
glucoside (676) has been isolated from Ornithogalum montanum
Cyr.388 and the main water soluble polysaccharide of the bulbs of
Ornithogalum ponticum (Zahar.) Speta was found to be a neutral
glucofructan with a glucose : fructose ratio of 30 : 1.57,389
A comparative study on the Bulgarian species Ornithogalum
nanum Sibth. & Sm., O. gussonei, Loncomelos narbonense (L.) Raf.
(as O. narbonense), and O. montanum Cyr. resulted in cardeno-
lides (677–681) being found in the bulbs of O. nanum and O.
gussonei but not in the bulbs of the other two species.390
The leaves and bulbs of the Turkish species Ornithogalum
alpigenum Stapf. have been tested for antioxidant activity, anti-
microbial activity and as free radical scavengers. The leaf extracts
were found to be good free radical scavengers (90.9%) and the
bulb extracts (methanol, ethanol, acetone and benzene) showed
variable activity against Candida albicans, Bacillus subtilis and
Bacillus cereus. The highest antioxidant activity was found in the
methanol extract of the bulbs (88.1% on a b-carotene-linoleic acid
system) and the lowest in the benzene extract of the bulbs.391 The
Iranian species Ornithogalum procerum Stapf. and Ornithogalum
cuspidatum Bertol. have received some attention. The aerial parts
of O. cuspidatum are used in Iran as food additives as well as an
anti-irritant and relaxant to soothe the throat when suﬀering from
a dry cough. The essential oils in the leaves, owers and bulbs
have been determined by GC-MS. The owers and bulbs contained
primarily saturated hydrocarbons, while the leaves contained
oxygenated hydrocarbons and terpenoid compounds.392 In addi-
tion, a GS-MS analysis of the methanol extract of the bulbs has
allowed for the identication of thirteen phytosterols (cholesterol,
3,5-didehydrostigmastan-6,22-diene, 4,4-dimethyl-5a-cholest-7-en-
3-one, 4b-methylcholesterol, 5-cholestene-3b,7b-diol, campesterol,
cholest-4-ene-3,6-dione, stigmast-4-en-3-one, stigmasta-3,5-dien-7-
one, stigmasterol, D5-ergostenol, b-sitosterol and g-sitosterol).393 A
GC-MS analysis of the aerial parts and bulbs of O. procerum
resulted in the identication of twenty-three essential oils in the
aerial parts and four polysterol-type compounds in the bulbs.394
Ornithogalum sintensii Freyn, another Iranian species, has been
tested for antioxidant activity. A higher phenolic and avonoid
content in the aerial parts of the plant relative to the bulbs,
accounted for the greater antioxidant activity in those extracts
(IC50 for DPPH radical scavenging activity of 368 and 669 mg ml
1
for leaves and bulbs respectively).395
Eliokarmos thyrsoides (Jacq.) Raf. is found in southwestern
South Africa. Although not reportedly used by traditional
healers it has been strongly linked to stock poisoning.1
Accordingly, the bulbs have been the subject of many phyto-
chemical investigations. An initial investigation of the meth-
anol extract of the bulbs in 1992 (as Ornithogalum thyrsoides)
resulted in the isolation of four cholestane bisdesmosides (682–
685), with 685 showing some inhibitory activity on cyclic AMP
phosphodiesterase (IC50 ¼ 15.3  105 M).396 Following the
discovery that the methanol extract of the bulbs showed potentThis journal is ª The Royal Society of Chemistry 2013
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Review NPRcytotoxicity against leukemia HL-60 cells (IC50 ¼ 0.79 mg ml1),
fractionation of this extract resulted in the isolation of twelve
bisdesmosidic cholestane glycosides (577–578, 686–694),397
seven cholestane glycosides (695–701) and nine spirocyclic
glycosides (702–710).398,399 The bisdesmosidic cholestane
glycosides with an aromatic acyl group at the C-16 diglycoside
were found to be the most cytotoxic (686 and 576) with IC50
values of 0.00016 and 0.00013 mg ml1 respectively. Compounds
687 and 696, the deacyl derivatives of compounds 688 and 689
and compounds 691 and 692 respectively did not show any
activity at all.400 Only moderate activity against leukemia HL-60
cells was found for the spirocyclic glycosides (IC50 of 1.6–5.3 mg
ml1).401 An arabinoglucuronomannoglycan has been isolated
from the leaves of E. thyrsoides (as O. thyrsoides).402 South
African bulbs of Stellarioides longibracteata (Jacq.) Speta areThis journal is ª The Royal Society of Chemistry 2013used extensively by the Zulu as an anti-inammatory, and
regionally to treat diabetes. A phytochemical investigation of
the bulbs (as Ornithogalum longibracteatum Jacq.) revealed one
major compound, the homoisoavanone 711.403 The water
extract of the bulbs produced a signicant increase in glucose
utilisation in Chang liver cells.404 Stellarioides longibracteata was
introduced to China many years ago and it is used in Chinese
folk medicine to treat cancer, as an antimicrobial, anti-inam-
matory and to treat hepatitis and parotitis.405 This species was
known earlier as Ornithogalum caudatum Ait. and as such many
papers and in particular patents, have been led under that
name. Spirosterols, caudaside A 712 and hecogenin 713 have
been isolated as well as b-sitosterol406 and three homoiso-
avanones (714–716).407 Compounds 714–716 were tested for
anti-tumour activity against P388 (mouse leukemia) and A-549Nat. Prod. Rep., 2013, 30, 1165–1210 | 1201
NPR Review(human pulmonary adenocarcinoma) but no activities were
noted. Later investigations of the bulbs of S. longibracteata (as
O. caudatum) resulted in the isolation of n-butyl pyroglumate
717, 26 additional known avonoids, sterols and acids408 and a
monoterpene lactone (6-hydroxy-4,4,7a-trimethyl-5,6,7,7a-tet-
rahydro-4H-benzofuran-2-one).409 A number of patents have
been led in China and Russia outlining methods for the
extraction of S. longibracteata (as O. caudatum) and use as a
treatment for cancer,410,411 cholecystitis and cholecystitis-related
diseases412 and for the isolation of the avonoid components for
use as an anti-inammatory and analgesic.413,414 Extracts from S.
longibracteata (as O. caudatum) have shown some benet in the
treatment of liver conditions.415,416 Four water soluble poly-
saccharide fractions have been extracted from S. longibracteata
(as O. caudatum) and have been found to have potential as
antitumour agents.417–419 Further work on the anti-cancer eﬀects
of this species has shown inhibition of MDA-MB-231 breast
cancer cells in a dose and time dependant manner.420 The bulbs
of Stellarioides tenuifolia (Redoute) Speta (as Ornithogalum ten-
uifolium Delaroche) yielded a crystalline steroidal saponin, 718,
with an unusual 5b conguration.421 This unusual conguration
at C-5, together with the 1b,3a hydroxyl group conguration,
results in a molecule with a shape that is able to undergo self-
recognition, similar to single-strand DNA, and thus form a
supramolecular zipper.
A review of steroidal glycosides isolated from various
monocot families (including Galtonia saundersiae, as Ornitho-
galum saundersiae) and their biological activities has been
published as well as a review of cholestane glycosides from G.
saundersiae, G. candicans and Eliokarmos thyrsoides (as Orni-
thogalum thyrsoides).422,4234 The Oziroe¨oideae
The genus Oziroe¨ Raf. (syn. Fortunatia Macbr.), is widespread in
South America and can be found in Peru, Chile, Bolivia, Para-
guay and north to central Argentina.424 No phytochemical
investigations have been recorded on these plant species.1202 | Nat. Prod. Rep., 2013, 30, 1165–12105 Conclusions
Research into the chemistry of the Hyacinthaceae has spanned
over 90 years and resulted in the isolation of over 700
compounds. The need to understand the chemistry was largely
fuelled by both the toxicity of the plants to stock and the
signicant ethnomedicinal applications associated with repre-
sentative species. In addition to the isolation of many
compounds of medicinal signicance, the phytochemical
studies have shed light on the classication of many of the
species. A thorough understanding of the chemistry and phar-
macology of these important plant species allows for the
potential discovery of new medical applications and further
aids the conservation of those taxa threatened with unsustain-
able utilisation by indicating alternatives with similarly active
constituents.6 Acknowledgements
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